Navigation Links
Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008
Date:3/11/2008

sels with excellent

specificity. The high degree of selective targeting seen in the study

provides additional evidence of bavituximab's therapeutic potential.

Bavituximab Anti-Viral Program: During the third quarter, the company continued to advance its bavituximab HCV program and presented positive data at a key liver disease meeting.
-- Added The Johns Hopkins Hospital and a private clinic in Orange

County, California as additional clinical study sites for the HCV/HIV

co-infection study.

-- Presented final results from the Phase I multiple dose HCV trial at

the prestigious Annual Meeting of the American Association for the

Study of Liver Disease that showed bavituximab was well tolerated and

demonstrated encouraging signs of anti-viral activity.

Cotara(R) Glioblastoma Program: Peregrine continued to advance the Cotara brain cancer program.
-- Added additional study sites and continued patient dosing and

follow-up in the Cotara Phase II study in patients with glioblastoma

multiforme, the most deadly form of brain cancer. Eight sites are now

open for patient enrollment.

-- Added an additional site, the Barrow Neurological Institute (BNI) in

Phoenix, Arizona, to the ongoing Cotara dosimetry and dose

confirmation clinical study. BNI also participated in a previous

Cotara Phase II clinical trial.

-- Announced positive results from the first cohort of patients treated

in the Cotara dosimetry trial and from the initial patients treated in

the Cotara Phase II trial. Cotara appeared safe and well tolerated

with no dose-limiting adverse events, with continuing patients being

monitored for overall survival. Several patients in these studies

have lived longer than the six-month expected median survival time for

this patient po
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Peregrine Pharmaceuticals to Announce Third Quarter FY 2008 Financial Results
2. Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity
3. Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer
4. Peregrine Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
5. Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008
6. Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program
7. Peregrine Pharmaceuticals to Announce Second Quarter FY 2008 Financial Results
8. New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti-Cancer Potential Of Peregrines Anti-PS Technology Platform
9. Peregrine Pharmaceuticals to Announce First Quarter FY 2008 Financial Results
10. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
11. Alseres Pharmaceuticals Presents Inosine and Dopamine Transporter (DAT) Blocker Preclinical Data at the American Society for Experimental NeuroTherapeutics (ASENT) Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Vermillion, Inc. (Pink Sheets: VRML), ... C. Wallen, Ph.D. Chief Scientific Officer, Senior ... Laboratories, will be joining its board of ... ,, "Bill brings more than 20 ... and biotechnology," said Gail Page, Vermillion Executive ...
(Date:12/14/2009)... third edition of Infusion Nursing: An ... the Infusion Nurses Society (INS), includes Totect(®), the ... are a group of chemotherapy medications including daunorubicin, ... in the treatment of various types of cancer ... to the INS publication: "In September 2007, the ...
(Date:12/14/2009)... Dec. 14 Nektar Therapeutics (Nasdaq: ... been appointed to serve on its board of ... leader with over 35 years of experience in ... brings to Nektar extensive industry perspective at an ... W. Robin, President and CEO of Nektar and ...
(Date:12/14/2009)... - Results From a Survey Conducted by UCB Assessing ... Countries , , - A third of ... impacts their enjoyment of the festive season, ... shopping for gifts, preparing holiday ... difficult to do, - Nearly ...
Breaking Biology Technology:Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 4
... Oct. 3 Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ... webcast live during the 4th Annual BIO Investor ... Eastern Time. The presentation,will be webcast from The ... the Investor Relations tab at http://www.alexza.com ...
... - Dr. Brad Thompson, President,and CEO of Oncolytics ... a,corporate overview of the Company at the 15th ... October 9 at 9 a.m. The conference,will be ... from October 7-9,2007. About Oncolytics Biotech Inc. ...
... eye for the,details hidden from casual view, a new ... of architectural details from beaches,to buildings and patterns to ... images from seven different countries., Well-known as a ... Genetics, is also a talented artist whose photography,is currently ...
Other Biology Technology:The 4th Annual BIO Investor Forum to Webcast Alexza's Corporate Presentation 2Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe 2An Uncommon Eye: Photography Exhibit by Biotechnology Executive at BHCC Gallery 2
(Date:12/15/2009)... environmental impacts, social dynamics, and production levels are ... of an agroecosystem. Positive or negative, these factors ... social groups to continuously adapt farming and food ... learning theory suggests that knowledge is gained as ... are especially valuable for environmental and agricultural educators ...
(Date:12/15/2009)... - Scientists at VIB and Ghent University in Flanders, ... of septic shock, the major cause of death in ... oxide (NO) gas in mice with septic shock, researchers ... organs showed much less damage, while their chances of ... it is generally assumed that nitric oxide is responsible ...
(Date:12/15/2009)... German ., Despite the fact that physical ... vary as to how space is encoded in their ... such as ,left, right, front, back, to talk about ... east, west, at all times for all scales: "The ... an snake by your Northern leg". Whether not only ...
Breaking Biology News(10 mins):Experiential learning teaches change and adaptation 2Septic shock: Nitric oxide beneficial after all 2More than a jump to the left 2Working Intensely Early on May Help Autistic Kids 62265 1Working Intensely Early on May Help Autistic Kids 62265 2Working Intensely Early on May Help Autistic Kids 62265 3Working Intensely Early on May Help Autistic Kids 62265 4Reportlinker Adds The Future of Senior Nutrition 3A Key Ingredients Strategic Issues and Targeted Opportunities for Older Consumers 62263 1Reportlinker Adds The Future of Senior Nutrition 3A Key Ingredients Strategic Issues and Targeted Opportunities for Older Consumers 62263 2Reportlinker Adds The Future of Senior Nutrition 3A Key Ingredients Strategic Issues and Targeted Opportunities for Older Consumers 62263 3Reportlinker Adds The Future of Senior Nutrition 3A Key Ingredients Strategic Issues and Targeted Opportunities for Older Consumers 62263 4Reportlinker Adds The Future of Senior Nutrition 3A Key Ingredients Strategic Issues and Targeted Opportunities for Older Consumers 62263 5Reportlinker Adds The Future of Senior Nutrition 3A Key Ingredients Strategic Issues and Targeted Opportunities for Older Consumers 62263 6Reportlinker Adds The Future of Senior Nutrition 3A Key Ingredients Strategic Issues and Targeted Opportunities for Older Consumers 62263 7Reportlinker Adds The Future of Senior Nutrition 3A Key Ingredients Strategic Issues and Targeted Opportunities for Older Consumers 62263 8Georgetown Hair Salon Helps St Jude Find A Cure 62261 1Georgetown Hair Salon Helps St Jude Find A Cure 62261 2
... Aug. 18 NeuralIQ, a developer of,cyber intelligence ... its global leadership team, headed by the appointment ... former Executive Vice President of Sales and strategy ... of NeuralIQ as the,company continues to advance its ...
... tucked away in the gut of Asian longhorned beetles ... according to a team of entomologists and biochemists. Researchers ... controlling the invasive pest, and potentially offer more efficient ... , Microbes in the gut of insects are known ...
... Atlantic Ocean shows that hot, dry air associated with ... contributor to the quieter-than-expected 2007 hurricane season. , Factors ... in a season, including El Nio, sea surface temperatures, ... [identify what agency made these forecasts; otherwise it might ...
Other Biology News:NeuralIQ Expands Global Leadership Team, Names Donnie Blanks CEO 2NeuralIQ Expands Global Leadership Team, Names Donnie Blanks CEO 3Novel fungus helps beetles to digest hard wood 2Novel fungus helps beetles to digest hard wood 32007 hurricane forecasts took blow from winds and Saharan dry, dusty air 22007 hurricane forecasts took blow from winds and Saharan dry, dusty air 3
...
...
... Class II safety cabinets Heraeus HERAsafe KS convince ... design. ,The new frameless slanted window does ... The new front window design makes it easy ... work aperture with a height of more than ...
... Thermo has recently launched a custom ... RNA (siRNA). Thermos siRNA molecules are: ... with 2 DNA bases overhang at ... Delivered fully deprotected and ready-to-use. ...
Biology Products: